Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2071 to 2085 of 7682 results

  1. MRI-based technologies for assessing non-alcoholic fatty liver disease (DG50)

    Evidence-based recommendations on MRI-based technologies for assessing non-alcoholic fatty liver disease

    Diagnostics guidance
    Published
    12 January 2023
    View recommendations

    Sections for DG50

  2. Quantitative faecal immunochemical testing to guide colorectal cancer pathway referral in primary care (DG56)

    Evidence-based recommendations on quantitative faecal immunochemical testing to guide colorectal cancer pathway referral in primary care

    Diagnostics guidance
    Published
    24 August 2023
    View recommendations

    Sections for DG56

  3. Virtual Touch Quantification to diagnose and monitor liver fibrosis in chronic hepatitis B and C (MTG27)

    Evidence-based recommendations on Virtual Touch Quantification to diagnose and monitor liver fibrosis in chronic hepatitis B and C.

    Medical technologies guidance
    Last updated
    17 January 2020
    View recommendations

    Sections for MTG27

  4. HumiGard for preventing inadvertent perioperative hypothermia (MTG31)

    Evidence-based recommendations on HumiGard for preventing inadvertent perioperative hypothermia.

    Medical technologies guidance
    Published
    8 February 2017
    View recommendations

    Sections for MTG31

  5. UroLift for treating lower urinary tract symptoms of benign prostatic hyperplasia (MTG58)

    Evidence-based recommendations on UroLift for treating lower urinary tract symptoms of benign prostatic hyperplasia.

    Medical technologies guidance
    Published
    4 May 2021
    View recommendations

    Sections for MTG58

  6. Episcissors-60 for mediolateral episiotomy (MTG47)

    Evidence-based recommendations on Episcissors-60 for mediolateral episiotomy.

    Medical technologies guidance
    Published
    11 February 2020
    View recommendations

    Sections for MTG47

  7. HeartFlow FFRCT for estimating fractional flow reserve from coronary CT angiography (MTG32)

    Evidence-based recommendations on HeartFlow FFRCT for estimating fractional flow reserve from coronary CT angiography.

    Medical technologies guidance
    Last updated
    19 May 2021
    View recommendations

    Sections for MTG32

  8. Kurin Lock for blood culture collection (MTG77)

    Evidence-based recommendations on Kurin Lock for blood culture collection.

    Medical technologies guidance
    Published
    3 April 2024
    View recommendations

    Sections for MTG77

  9. Neuropad for detecting preclinical diabetic peripheral neuropathy (MTG38)

    Evidence-based recommendations on Neuropad for detecting preclinical diabetic peripheral neuropathy.

    Medical technologies guidance
    Last updated
    21 September 2022
    View recommendations

    Sections for MTG38

  10. Pegcetacoplan for treating geographic atrophy [ID4041]

    In development [GID-TA11351] Expected publication date: TBC

    Technology appraisal guidance
    In development

  11. Rapid tests for group A streptococcal infections in people with a sore throat (DG38)

    Evidence-based recommendations on rapid tests for group A streptococcal infections in people aged 5 and over with a sore throat

    Diagnostics guidance
    Published
    13 November 2019
    View recommendations

    Sections for DG38

  12. SepsiTest assay for rapidly identifying bloodstream bacteria and fungi (DG20)

    Evidence-based recommendations on the SepsiTest assay for rapidly identifying bloodstream bacteria and fungi

    Diagnostics guidance
    Last updated
    19 February 2020

    Sections for DG20

  13. Tucatinib with trastuzumab and pertuzumab for maintenance treatment of HER2-positive unresectable advanced breast cancer after induction chemotherapy [ID6402]

    Awaiting development [GID-TA11487] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  14. Pegargiminase with pemetrexed and cisplatin for untreated advanced malignant pleural mesothelioma [ID1575]

    Awaiting development [GID-TA10486] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  15. Vonicog alfa for preventing haemorrhage in people with von Willebrand disease when desmopressin is ineffective or not suitable ID 6272

      Status ...

    Health technology evaluations
    Topic selection